ABSTRACT The RenOx platform integrates lung and kidney support within a single extracorporeal device designed to reflect the clinical realities of multiorgan failure. Early preclinical work demonstrates the feasibility of combined gas exchange and renal support, suggesting that a unified lung–kidney device could reduce the burden of multi‐device management, streamline intensive care workflows, and potentially improve outcomes in patients with combined organ failure.